|
Objective: To investigate the improved cryosurgical joint in the value of the medical treatment of lung cancer , for the pharmaceutical clinical application cryosurgical joint to provide guidance and technical support , a more sophisticated treatment programs to explore the treatment of lung cancer . Methods: This subject prospective study and retrospective study combined with each other , specifically, is through targeted cryoablation surgery combined with the medical treatment of patients with lung cancer surgery and postoperative concurrent 122 cases through improved cryosurgical disease , quality of life , survival period , the total lifetime of the observation . Results: 122 patients with lung cancer using cryoablation therapy treatment improved the successful completion of the surgery , no case of surgery died . 30 cases no significant adverse reactions , 42 patients with a cough or coughing heavier than the preoperative and postoperative wound pain or chest pain than before surgery increased by 42 cases , 29 cases of fever , 10 cases of pneumothorax , 20 patients with sputum blood after emerging pleural effusion in 12 cases , accounting for 9.84% , six cases of subcutaneous emphysema , eight cases of pulmonary infection . The cryotherapy and conclusions : 1 , cryosurgical targeted efficacy of Chinese medicine treatment of lung cancer , can be effective ablation of localized lesions , reduce patient suffering , improve the patient 's quality of life and prolong the survival of lung cancer patients . 2 cryosurgical trauma , faster recovery after the patient 's tolerance of and adapt to the crowd . 3 , an improved surgical approach can reduce surgical difficulty and risk , improve treatment efficiency , while reducing complications .
|